152 related articles for article (PubMed ID: 34931793)
1. siRNA-Based Carrier-Free System for Synergistic Chemo/Chemodynamic/RNAi Therapy of Drug-Resistant Tumors.
Jiang Y; Liu Y; Wang M; Li Z; Su L; Xu X; Xing C; Li J; Lin L; Lu C; Yang H
ACS Appl Mater Interfaces; 2022 Jan; 14(1):361-372. PubMed ID: 34931793
[TBL] [Abstract][Full Text] [Related]
2. Tumor Microenvironment-Activated Theranostics Nanozymes for Fluorescence Imaging and Enhanced Chemo-Chemodynamic Therapy of Tumors.
Zhao DH; Li CQ; Hou XL; Xie XT; Zhang B; Wu GY; Jin F; Zhao YD; Liu B
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55780-55789. PubMed ID: 34787410
[TBL] [Abstract][Full Text] [Related]
3. NIR-II light triggered nitric oxide release nanoplatform combined chemo-photothermal therapy for overcoming multidrug resistant cancer.
Wang J; Wu C; Qin X; Huang Y; Zhang J; Chen T; Wang Y; Ding Y; Yao Y
J Mater Chem B; 2021 Feb; 9(6):1698-1706. PubMed ID: 33495772
[TBL] [Abstract][Full Text] [Related]
4. Cascade-Reaction-Based Nanodrug for Combined Chemo/Starvation/Chemodynamic Therapy against Multidrug-Resistant Tumors.
Chen Y; Yao Y; Zhou X; Liao C; Dai X; Liu J; Yu Y; Zhang S
ACS Appl Mater Interfaces; 2019 Dec; 11(49):46112-46123. PubMed ID: 31722522
[TBL] [Abstract][Full Text] [Related]
5. Lenvatinib-zinc phthalocyanine conjugates as potential agents for enhancing synergistic therapy of multidrug-resistant cancer by glutathione depletion.
Wei G; Huang L; Jiang Y; Shen Y; Huang Z; Huang Y; Sun X; Zhao C
Eur J Med Chem; 2019 May; 169():53-64. PubMed ID: 30856406
[TBL] [Abstract][Full Text] [Related]
6. Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors.
Wang C; Guan W; Peng J; Chen Y; Xu G; Dou H
Acta Biomater; 2020 Feb; 103():247-258. PubMed ID: 31846802
[TBL] [Abstract][Full Text] [Related]
7. Supra-Carbon Dots Formed by Fe
Chen Q; Sun S; Lin H; Li Z; Wu A; Liu X; Wu FG; Zhang W
ACS Appl Bio Mater; 2021 Mar; 4(3):2759-2768. PubMed ID: 35014315
[TBL] [Abstract][Full Text] [Related]
8. PLGA nanoparticles co-delivering MDR1 and BCL2 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer.
Risnayanti C; Jang YS; Lee J; Ahn HJ
Sci Rep; 2018 May; 8(1):7498. PubMed ID: 29760419
[TBL] [Abstract][Full Text] [Related]
9. Copper efflux transporter (ATP7B) contributes to the acquisition of cisplatin-resistance in human oral squamous cell lines.
Yoshizawa K; Nozaki S; Kitahara H; Ohara T; Kato K; Kawashiri S; Yamamoto E
Oncol Rep; 2007 Oct; 18(4):987-91. PubMed ID: 17786364
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide-releasing micelles with intelligent targeting for enhanced anti-tumor effect of cisplatin in hypoxia.
Chen Y; Fang L; Zhou W; Chang J; Zhang X; He C; Chen C; Yan R; Yan Y; Lu Y; Xu C; Xiang G
J Nanobiotechnology; 2021 Aug; 19(1):246. PubMed ID: 34399762
[TBL] [Abstract][Full Text] [Related]
11. Sulforaphane Mediates Glutathione Depletion via Polymeric Nanoparticles to Restore Cisplatin Chemosensitivity.
Xu Y; Han X; Li Y; Min H; Zhao X; Zhang Y; Qi Y; Shi J; Qi S; Bao Y; Nie G
ACS Nano; 2019 Nov; 13(11):13445-13455. PubMed ID: 31670945
[TBL] [Abstract][Full Text] [Related]
12. Boosting Chemodynamic Therapy
Yao J; Yang F; Zheng F; Yao C; Xing J; Xu X; Wu A
ACS Appl Mater Interfaces; 2021 Nov; 13(46):54770-54782. PubMed ID: 34780685
[TBL] [Abstract][Full Text] [Related]
13. Peptide-Based Autophagic Gene and Cisplatin Co-delivery Systems Enable Improved Chemotherapy Resistance.
Lin YX; Wang Y; An HW; Qi B; Wang J; Wang L; Shi J; Mei L; Wang H
Nano Lett; 2019 May; 19(5):2968-2978. PubMed ID: 30924343
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable copper-metformin nanoscale coordination polymers for enhanced chemo/chemodynamic synergistic therapy by reducing oxygen consumption to promote H
Meng X; Zhang X; Lei Y; Cao D; Wang Z
J Mater Chem B; 2021 Mar; 9(8):1988-2000. PubMed ID: 33511387
[TBL] [Abstract][Full Text] [Related]
15. Codelivery of CPT and siPHB1 with GSH/ROS Dual-Responsive Hybrid Nanoparticles Based on a [12]aneN
Liang YX; Sun XY; Xu DZ; Gao YN; Tang Q; Lu ZL; Liu Y
ACS Appl Bio Mater; 2024 May; 7(5):3202-3214. PubMed ID: 38651918
[TBL] [Abstract][Full Text] [Related]
16. Biodegradable Nanocatalyst with Self-Supplying Fenton-like Ions and H
Li W; Zhou X; Liu S; Zhou J; Ding H; Gai S; Li R; Zhong L; Jiang H; Yang P
ACS Appl Mater Interfaces; 2021 Nov; 13(43):50760-50773. PubMed ID: 34672620
[TBL] [Abstract][Full Text] [Related]
17. Novel multi-stimuli responsive functionalized PEG-based co-delivery nanovehicles toward sustainable treatments of multidrug resistant tumor.
Xu J; Yan X; Ge X; Zhang M; Dang X; Yang Y; Xu F; Luo Y; Li G
J Mater Chem B; 2021 Feb; 9(5):1297-1314. PubMed ID: 33443252
[TBL] [Abstract][Full Text] [Related]
18. Chitosan coated polylactic acid nanoparticle-mediated combinatorial delivery of cisplatin and siRNA/Plasmid DNA chemosensitizes cisplatin-resistant human ovarian cancer cells.
Babu A; Wang Q; Muralidharan R; Shanker M; Munshi A; Ramesh R
Mol Pharm; 2014 Aug; 11(8):2720-33. PubMed ID: 24922589
[TBL] [Abstract][Full Text] [Related]
19. Multi-mechanism antitumor/antibacterial effects of Cu-EGCG self-assembling nanocomposite in tumor nanotherapy and drug-resistant bacterial wound infections.
Chen Y; Li H; Liu N; Feng D; Wu W; Gu K; Wu A; Li C; Wang X
J Colloid Interface Sci; 2024 Oct; 671():751-769. PubMed ID: 38824748
[TBL] [Abstract][Full Text] [Related]
20. Nanoscale metal-organic frameworks for the co-delivery of cisplatin and pooled siRNAs to enhance therapeutic efficacy in drug-resistant ovarian cancer cells.
He C; Lu K; Liu D; Lin W
J Am Chem Soc; 2014 Apr; 136(14):5181-4. PubMed ID: 24669930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
